Evidence map›Paper›PMID 42231314›Full record

ArticleBMC public health2026

Development of a comprehensive real-world evidence dataset to inform diabetes policy: the diabetes data cell project.

A Lavens, D Jaminé, M Urbina, B Vaes, C Mathieu, F Nobels, Steering committee of the Diabetes Data Cell Project

Abstract read
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A LavensHealth Services Research, Sciensano, Brussels, Belgium. astrid.lavens@sciensano.be.ORCID http://orcid.org/0000-0002-9942-8263
D JaminéIntermutualistic Agency, Brussels, Belgium.
M UrbinaIntermutualistic Agency, Brussels, Belgium.
B VaesDepartment of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-5244-1930
C MathieuClinical and Experimental Endocrinology, University Hospitals Leuven-KUL, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4055-5233
F NobelsDepartment of Endocrinology, AZORG, Aalst, Belgium.ORCID http://orcid.org/0000-0002-8058-8734
Steering committee of the Diabetes Data Cell Project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes is a highly prevalent non-communicable disease with a growing global burden, posing significant challenges to healthcare systems. Effective management requires comprehensive monitoring of prevalence, risk factors, and outcomes across diverse diabetes populations. While several European countries have established or are establishing national diabetes registries to guide care and policy, Belgium's diabetes data landscape remains fragmented, lacking a unified national diabetes registry. Existing datasets cover limited populations and care settings, hindering a complete understanding of diabetes care and prevalence. To address this, the Belgian Diabetes Forum initiated the Diabetes Data Cell Project, aiming to integrate multiple healthcare datasets and create a comprehensive national diabetes registry.

methodsAn inventory of existing databases was compiled, and the quality of the datasets was assessed based on predefined criteria. A selection of core datasets was made to ensure reliable identification of individuals with diabetes, based on clinical diagnoses and coverage of the entire healthcare spectrum. Complementary datasets were selected to enrich the core datasets with additional information on healthcare utilization and mortality. All datasets had to allow for linkage at the individual level and provide longitudinal data.

resultsWe identified two large core datasets of people with diabetes who are treated in primary care and in hospital outpatient clinics. We obtained permission from the Information Security Commission to link both sets for the period 2017-2027 at the individual level to the national insurance dataset - where all medical procedures are recorded. That insurance dataset is also linked to mortality data. The first data extraction, covering 2017-2024, resulted in a linked dataset of 76 964 unique individuals. The combined dataset provides a comprehensive overview of diabetes diagnosis and type, diabetes duration, demographic characteristics, clinical outcomes, laboratory results, medications and other treatments, medical procedures and hospitalizations, complications, healthcare utilization, mortality and costs of care.

conclusionsThis study demonstrates that large-scale linkage of Belgian health data is feasible within the current legal and technical framework and enables the identification of people living with diabetes across both primary and specialized care. By integrating clinical and administrative datasets at the individual level, the project provides a comprehensive and longitudinal view of diabetes care, supporting analyses of treatment patterns, care processes, outcomes, and healthcare utilization. This work lays the foundation for a continuously updated, 'living' national diabetes registry in Belgium and represents an important step towards more integrated, data-driven healthcare policy.

Indexed as

Databases, FactualDatasets as TopicDiabetes MellitusHealth PolicyRegistriesBelgiumFemaleHumansSecondary Data AnalysisData linkageDiabetesHealth administrative dataHealth policyNational diabetes registryNon-communicable disease monitoringReal-world data

Identifiers

PMID42231314
PMCPMC13445860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.